XML 13 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Income and Comprehensive Income - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenues $ 87,190 $ 85,531
Cost of Products Sold 61,607 59,299
Gross Profit 25,583 26,232
Operating Expenses:    
Research and Development 4,508 4,737
Selling, General and Administrative 14,520 15,019
Total Operating Expenses 19,028 19,756
Operating Income 6,555 6,476
Other Expense (Income):    
Interest and Financing Expense 63 183
Miscellaneous (121) (2)
Income Before Income Taxes 6,613 6,295
Income Tax Benefit (Expenses) 18,386 1,369
Net Income 24,999 7,664
Net Income Attributable to Non-Controlling Interest 69 16
Net Income Attributable to Ultralife Corporation 24,930 7,648
Other Comprehensive (Loss) Income:    
Foreign Currency Translation Adjustments (1,175) 1,469
Comprehensive Income Attributable to Ultralife Corporation $ 23,755 $ 9,117
Net Income Per Share Attributable to Ultralife Corporation Common Shareholders – Basic: (in dollars per share) $ 1.57 $ 0.49
Net Income Per Share Attributable to Ultralife Corporation Common Shareholders – Diluted: (in dollars per share) $ 1.53 $ 0.48
Weighted Average Shares Outstanding – Basic (in shares) 15,882 15,528
Weighted Average Shares Outstanding – Diluted (in shares) 16,347 15,858